本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ikena Oncology, Inc.

1.42
+0.12009.23%
盘后1.40-0.0200-1.41%19:31 EDT
成交量:21.33万
成交额:29.95万
市值:6,852.65万
市盈率:-1.64
高:1.43
开:1.33
低:1.33
收:1.30
数据加载中...
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/03/06

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/12/23

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/12/23

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/12

重要事件披露

Form 8-K - Current report
2024/06/10

重要事件披露

Form 8-K - Current report
2024/05/28

重要事件披露

Form 8-K - Current report
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/21

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report